Medical Marijuana and Marijuana Legalization

Annual Review of Clinical Psychology

Volumn 13, Issue , 2017, Pages 397-419

  Pacula, Rosalie Liccardo ^a,b   Smart, Rosanna ^a  

^a RAND CORPORATION   (United States)

^b NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

Author keywords

Marijuana liberalization; Marijuana products; Policy dynamics; Policy heterogeneity

Indexed keywords

CANNABIS; MEDICAL CANNABIS;

ARTICLE; CANNABIS USE; DRUG LEGISLATION; ENVIRONMENTAL POLICY; EVALUATION STUDY; HUMAN; MEDICALIZATION; LEGISLATION AND JURISPRUDENCE;

HUMANS; LEGISLATION, DRUG; MARIJUANA USE; MEDICAL MARIJUANA;

EID: 85019065525     PISSN: 15485943     EISSN: 15485951     Source Type: Book Series    
DOI: 10.1146/annurev-clinpsy-032816-045128     Document Type: Article

References (114)

1. Anderson DM, Hansen B, Rees DI. 2012. Medical marijuana laws and teen marijuana use. Disc. Pap. 6592, IZA, Bonn, Ger
2. Anderson DM, Hansen B, Rees DI. 2013. Medical marijuana laws, traffic fatalities, and alcohol consumption. J. Law Econ. 56:333-69
3. Anderson DM, Hansen B, Rees DI. 2015. Medical marijuana laws and teen marijuana use.Am. Law Econ. Rev. 17(2):495-528
4. Anderson DM, Rees DI. 2014. The role of dispensaries: The devil is in the details. J. Policy Anal. Manag. 33(1):235-40
5. Armbrister M. 2016. Colorado pot potency ballot initiative is withdrawn. Denver Bus. J., Jul. 8
6. Asbridge M, Duff C, Marsh DC, Erickson PG. 2014. Problems with the identification of "problematic" cannabis use: examining the issues of frequency, quantity, and drug use environment. Eur. Addict. Res. 20:254-67
7. Bachhuber MA, Saloner B, Cunningham CO, Barry CL. 2014. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern. Med. 174(10):1668-73
8. Baker D. 2007. N.M.:Won't oversee marijuana production. Assoc. Press, Aug. 16
9. Borodovsky JT, Crosier BS, Lee DC, Sargent JD, Budney AJ. 2016. Smoking, vaping, eating: Is legalization impacting the way people use cannabis? Int. J. Drug Policy 36:141-47
10. Boyd CJ, Veliz PT, McCabe SE. 2015. Adolescents' use of medical marijuana: a secondary analysis of Monitoring the Future data. J. Adolesc. Health 57(2):241-44
11. Burns RM, Caulkins JP, Everingham SS, Kilmer B. 2013. Statistics on cannabis users skew perceptions of cannabis use. Front. Psychiatry 4(138):1-10
12. Caulkins JP, Hawken A, Kilmer B, Kleiman M. 2012. Marijuana Legalization: What Everyone Needs to Know. New York: Oxford Univ. Press
13. Caulkins JP, Kilmer B. 2016. Considering marijuana legalization carefully: insights for other jurisdictions from analysis for Vermont. Addiction 111(12):2082-89
14. Caulkins JP, Kilmer B, Kleiman MAR, MacCoun RJ, Midgette G, et al. 2015. Considering Marijuana Legalization: Insights for Vermont and Other Jurisdictions. Santa Monica, CA: RAND Corp
15. CerdáM,Wall M, Keyes KM, Galea S,Hasin DS. 2012. Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug Alcohol Depend. 120:22-27
16. Choi A. 2014. The impact of medical marijuana laws on marijuana use and other risky health behaviors. Presented at ASHE Conf., 5th, Los Angeles
17. Choo EK, Benz M, Zaller N, Warren O, Rising KL, McConnell KJ. 2014. The impact of state medical marijuana legislation on adolescent marijuana use. J. Adolesc. Health 55(2):160-66
18. Chu YWL. 2014. The effects of medical marijuana laws on illegal marijuana use. J. Health Econ. 38:43-61
19. Collett SC, Gariffo T, Hernandez-Morgan M. 2013. Evaluation of theMedical Marijuana Program inWashington, D.C. Los Angeles: UCLA
20. ComptonWM, Baler R. 2016. The epidemiology ofDSM-5 cannabis use disorders among U.S. adults: science to inform clinicians working in a shifting social landscape. Am. J. Psychiatry 173(6):551-53
21. D'Amico EJ, Miles JNV, Tucker JS. 2015. Gateway to curiosity: medical marijuana ads and intention and use during middle school. Psychol. Addict. Behav. 29(3):613-19
22. Davenport SS, Caulkins JP. 2016. Evolution of the United States: marijuana market in the decade of liberalization before full legalization. J. Drug Issues 46(4):411-27
23. DeSimone J, Farrelly MC. 2003. Price and enforcement effects on cocaine and marijuana demand. Econ. Inquiry 41:98-115
24. Dinardo J, Lemieux T. 2001. Alcohol, marijuana, and American youth: the unintended consequences of government regulation. J. Health Econ. 20(6):991-1010
25. Fairman BJ. 2015. Trends in registered medical marijuana participation rates across 13 US states and District of Columbia. Drug Alcohol Depend. 159:72-79
26. Fischer B, Kuganesan S, Room R. 2015. Medical marijuana programs: implications for cannabis control policy-observations from Canada. Int. J. Drug Policy 26(1):15-19
27. Fox CR, Tannenbaum D. 2011. The elusive search for stable risk preferences. Front. Psychol. 2:298
28. Galenianos M, Pacula RL, Persico N. 2012. A search-theoretic model of the retail market for illicit drugs. Rev. Econ. Studies 79:1239-69
29. Gettman J. 2015a. Marijuana Arrests in Colorado After the Passage of Amendment 64. New York: Drug Policy Alliance
30. Gettman J. 2015b. Status Report: Marijuana Legalization inWashington After 1 Year of Retail Sales and 2.5 Years of Legal Possession. New York: Drug Policy Alliance
31. Gordon AJ, Conley JW, Gordon JM. 2013. Medical consequences of marijuana use: a review of the current literature. Curr. Psychiatry Rep. 15(12):419
32. Gorman DM,Huber J. 2007. Do medical cannabis laws encourage cannabis use? Int. J. Drug Policy 18(3):160-67
33. Haardörfer R, Berg CJ, Lewis M, Payne J, Pillai D, et al. 2016. Polytobacco, marijuana, and alcohol use patterns in college students: a latent class analysis. Addict. Behav. 59:58-64
34. Hall W. 2009. The adverse health effects of cannabis use:What are they, and what are their implications for policy? Int. J. Drug Policy 20(6):458-66
35. Hall W. 2015. What has research over the past two decades revealed about the adverse effects of cannabis use? Addiction 110(1):19-35
36. Hall W, Lynskey M. 2016. Evaluating the public health impacts of legalizing recreational cannabis use in the United States. Addiction 111(10):1764-73
37. HaneyM, Evins AE. 2016. Does cannabis cause, exacerbate, or ameliorate psychiatric disorders? An oversimplified debate discussed. Neuropsychopharmacology 41(2):393-401
38. Harper S, Strumpf EC, Kaufman JS. 2012. Do medical marijuana laws increase marijuana use? Replication study and extension. Ann. Epidemiol. 22(3):207-12
39. Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, et al. 2013. DSM-5 criteria for substance use disorders: recommendations and rationale. Am. J. Psychiatry 170:834-51
40. HasinDS, Saha TD,Kerridge BT, Goldstein RB, Chou SP, et al. 2015a. Prevalence ofmarijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry 72(12):1235-42
41. Hasin DS, Wall M, Keyes KM, CerdáM, Schulenberg J, et al. 2015b.Medical marijuana laws and adolescent marijuana use in the USA from 1991-2014: results from annual, repeated cross-sectional surveys. Lancet Psychiatry 2(7):601-8
42. Hill KP. 2015. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review. JAMA 313(24):2474-83
43. Huestis MA. 2007. Human cannabinoid pharmacokinetics. Chem. Biodivers. 4(8):1770-804
44. Hughes JR, Fingar JR, Budney AJ, Naud S, Helzer JE. 2014. Marijuana use and intoxication among daily users: an intensive longitudinal study. Addict. Behav. 39(10):1464-70
45. Humphreys K. 2016. So, something interesting happens to weed after it's legal. The Washington Post Wonkblog, May 4. https://www.washingtonpost.com/news/wonk/wp/2016/05/04/the-priceof-legal-pot-is-collapsing/
46. Hunt PE,Miles J. 2015. The impact of legalizing and regulating weed: issues with study design and emerging findings in the USA. Curr. Topics Behav. Neurosci. https://doi.org/10.1007/7854-2015-423
47. Johnston D, Lewis NA. 2009. Ending raids of dispensers of marijuana for patients. New York Times, March 18, p. A20
48. Johnston LD, O'Malley PM, Bachman JG. 1981. Marijuana decriminalization: the impact on youth 1975-1980. Monitoring the Future Occas. Pap. 13, Inst. Soc. Res., Univ. Mich., Ann Arbor
49. Keyes KM, Wall M, Cerdá M, Schulenberg J, O'Malley PM, et al. 2016. How does state marijuana policy affect US youth? Medical marijuana laws, marijuana use and perceived harmfulness: 1991-2014. Addiction 111:2187-95. https://doi.org/10.1111/add.13523
50. Khatapoush S, Hallfors D. 2004. "Sending the wrong message": Did medical marijuana legalization in California change attitudes about and use of marijuana? J. Drug Issues 34:741-70
51. Kilmer B, Caulkins JP, Pacula RL, MacCoun RJ, Reuter P. 2010. Altered State? Assessing How Marijuana Legalization in California Could Influence Marijuana Consumption and Public Budgets. Santa Monica, CA: RAND Corp
52. Kilmer JR, Hunt SB, Lee CM, Neighbors C. 2007. Marijuana use, risk perception, and consequences: Is perceived risk congruent with reality? Addict. Behav. 32:3026-33
53. King E, Behrman J. 2009. Timing and duration of exposure in evaluations of social programs. World Bank Econ. Rev. 22:539-66
54. KoppelBS, Brust JC, Fife T, Bronstein J,Youssof S, et al. 2014. Systematic review: efficacy and safety ofmedical marijuana in selected neurologic disorders. Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 82(17):1556-63
55. Kosterman R, Bailey JA, Guttmannova K, Jones TM, Eisenberg N, et al. 2016. Marijuana legalization and parents' attitudes, use, and parenting in Washington State. J. Adolesc. Health 59(4):450-56
56. Loflin M, Earleywine M. 2014. A new method of cannabis ingestion: the dangers of dabs? Addict. Behav. 39(10):1430-33
57. Lynne-Landsman SD, Livingston MD, Wagenaar AC. 2013. Effects of state medical marijuana laws on adolescent marijuana use. Am. J. Public Health 103(8):1500-6
58. MacCoun R, Pacula RL, Chriqui JF, Harris K, Reuter P. 2009. Do citizens know whether their state has decriminalized marijuana? Assessing the perceptual component of deterrence theory. Rev. Law Econ. 5:347-71
59. MacCoun R, Reuter P. 2001. Evaluating alternative cannabis regimes. Br. J. Psychiatry 178:123-28
60. Maloff D. 1981. A review of the effects of the decriminalization of marijuana. Contemp. Drug Probl. 10:307-22
61. MarijuanaWork. Group. 2016. Initiative 71: Marijuana Working Group Status Report.Washington, DC: Gov. D.C
62. Markowitz S, Tauras J. 2009. Substance use among adolescent students with consideration of budget constraints. Rev. Econ. Househ. 7:423-46
63. Miech RA, Johnston L, O'Malley PM, Bachman JG, Schulenberg J, Patrick ME. 2015. Trends in use of marijuana and attitudes toward marijuana among youth before and after decriminalization: the case of California 2007-2013. Int. J. Drug Policy 26:336-44
64. Model K. 1993. The effect of marijuana decriminalization on hospital emergency room episodes: 1975-1978. J. Am. Stat. Assoc. 88(423):737-47
65. Natl. Comm. Marihuana Drug Abus. 1972. Marihuana: a signal of misunderstanding. First Rep. Natl. Comm. Marihuana Drug Abus., US Gov. Print. Off.,Washington, DC
66. NCSL (Natl. Conf. State Legis). 2016a. Marijuana overview, Aug. 2. http://www.ncsl.org/research/ civil-and-criminal-justice/marijuana-overview.aspx
67. NCSL (Natl. Conf. State Legis). 2016b. State medical marijuana laws, Jul. 20. http://www.ncsl.org/ research/health/state-medical-marijuana-laws.aspx
68. Nussbaum AM, Thurstone C,McGarry L, Walker B, Sabel AL. 2015. Use and diversion of medical marijuana among adults admitted to inpatient psychiatry. Am. J. Drug Alcohol Abus. 41(2):166-72
69. OgdenDW.2009. Investigations and Prosecutions in States Authorizing theMedical Use of Marijuana:Memorandum for Selected United States Attorneys. Washington,DC: US Dep. Justice, Off. Deputy Atty
70. Pacula RL. 1998. Does increasing the beer tax reduce marijuana consumption? J. Health Econ. 17(5):557-86
71. Pacula RL, Boustead A, Hunt P. 2014a.Words can be deceiving: a review of variation among legally effective medical marijuana laws in the United States. J. Drug Policy Anal. 7(1):1-19
72. Pacula RL,Chriqui JF, King J. 2003. Decriminalization in the United States: What does it mean? Work. Pap. 9690, NBER, Cambridge, MA
73. Pacula RL, Chriqui JF, Reichmann DA, Terry-McElrath YM. 2002. State medical marijuana laws: understanding the laws and their limitations. J. Public Health Policy 23(4):413-39
74. Pacula RL,HeatonP,PowellD, Sevigny EL. 2015. Assessing the effects of medical marijuana laws onmarijuana use: The devil is in the details. J. Policy Anal. Manag. 34(1):7-31
75. Pacula RL, Jacobson M, Maksabedian EJ. 2016. In the weeds: a baseline view of cannabis use among legalizing states and their neighbors. Addiction 111:973-80
76. Pacula RL, Kilmer B, Grossman M, Chaloupka FJ. 2010. Risks and prices: the role of user sanctions in marijuana markets. B. E. J. Econ. Anal. Policy 10(1):1-36
77. Pacula RL, Kilmer B, Wagenaar AC, Chaloupka FJ, Caulkins JP. 2014b.Developing public health regulations for marijuana: lessons from alcohol and tobacco. Am. J. Public Health 104(6):1021-28
78. Pacula RL, Lundberg R. 2014. Why changes in price matter when thinking about marijuana policy: a review of the literature on the elasticity of demand. Public Health Rev. 35(2):1-18
79. Pacula RL,MacCoun R, Reuter P, Chriqui J, Kilmer B, et al. 2005. What does it mean to decriminalize marijuana? A cross-national empirical examination. In Substance Abuse: Individual Behaviour, Social Interactions, Markets and Politics, Vol. 16, ed. M Grossman, B Lindgren, pp. 347-70. Amsterdam: Elsevier
80. Pacula RL, PowellD,Heaton P, Sevigny E. 2015. Assessing the effects of medical marijuana laws onmarijuana: The devil is in the details. J. Public Policy Anal. Manag. 34:7-31
81. Pacula RL, Sevigny EL. 2014a.Marijuana liberalization policies: why we can't learn much from policy still in motion. J. Policy Anal. Manag. 33(1):212-21
82. Pacula RL, Sevigny EL. 2014b. Natural experiments in a complex and dynamic environment: the need for measured assessment of the evidence. J. Policy Anal. Manag. 33(1):232-35
83. Pertwee R. 2014. Handbook of Cannabis. Oxford, UK: Oxford Univ. Press
84. Raphael S, Stoll MA. 2013. Why Are So Many Americans in Prison? New York: Russell Sage Found
85. Rendon J. 2013. Super-Charged: How Outlaws, Hippies, and Scientists Reinvented Marijuana. Portland, OR: Timber Press
86. Reuter P, Hirschfield P, Davies C. 2001. Assessing the Crackdown on Marijuana in Maryland. Baltimore, MD: Abell Found
87. Reuter P, MacCoun RJ. 1995. Assessing the legalization debate. In Policies and Strategies to Combat Drugs in Europe, ed. G Estievenart, pp. 39-49. Amsterdam: Kluwer
88. Ritter A, Livingston M, Chalmers J, Berends L, Reuter P. 2016. Comparative policy analysis for alcohol and drugs: current state of the field. Int. J. Drug Policy 31:39-50
89. Ross A, Walker A. 2017. The impact of low-priority laws on criminal activity: evidence from California. Contemp. Econ. Policy. In press. https://doi.org/10.1111/coep.12179
90. Russo EB, Guy GW, Robson PJ. 2007. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chem. Biodivers. 4(8):1729-43
91. Saffer H, Chaloupka FJ. 1999. The demand for illicit drugs. Econ. Inq. 37(3):401-11
92. Salomonsen-Sautel S, Sakai JT, Thurstone C, Corley R, Hopfer C. 2012. Medical marijuana use among adolescents in substance abuse treatment. J. Am. Acad. Child Adolesc. Psychiatry 51(7):694-702
93. Schauer GL, King BA, Bunnell RE, Promoff G, McAfee TA. 2016. Toking, vaping, and eating for health or fun: marijuana use patterns in adults, U.S., 2014. Am. J. Prev. Med. 50(1):1-8
94. Schuermeyer J, Salomonsen-Sautel S, Price RK, Balan S, Thurstone C, et al. 2014. Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003-2011. Drug Alcohol Depend. 140:145-55
95. Sevigny EL. 2014. Medical marijuana by the numbers. Presented at Annu. Conf. Int. Soc. Study Drug Policy, 8th, Rome
96. Sevigny EL, Pacula RL, Heaton P. 2014. The effects of medical marijuana laws on potency. Int. J. Drug Policy 25:308-19
97. Single E. 1989. The impact of marijuana decriminalization: an update. J. Public Health Policy 10:456-66
98. Smart R. 2016. Essays on the effects of medical marijuana laws. PhD Thesis, Univ. Calif., Los Angeles
99. Sobesky M, Gorgens K. 2016. Cannabis and adolescents: exploring the substance misuse treatment provider experience in a climate of legalization. Int. J. Drug Policy 33:66-74
100. Stringer RJ, Maggard SR. 2016. Reefer madness to marijuana legalization: media exposure and American attitudes toward marijuana (1975-2012). J. Drug Issues 46(4):428-45
101. SubbaramanMS, Kerr WC. 2015. Simultaneous versus concurrent use of alcohol and cannabis in the National Alcohol Survey. Alcohol. Clin. Exp. Res. 39(5):872-79
102. Subritzky T, Pettigrew S, Lenton S. 2016. Issues in the implementation and evolution of the commercial recreational cannabis market in Colorado. Int. J. Drug Policy 27:1-12
103. Sumnall HR, Tyler E, WagstaffGF, Cole JC. 2004. A behavioural economic analysis of alcohol, amphetamine, cocaine and ecstasy purchases by polysubstance misusers. Drug Alcohol Depend. 76(1):93-99
104. Temple EC, Brown RF, Hine DW. 2011. The "grass ceiling": Limitations in the literature hinder our understanding of cannabis use and its consequences. Addiction 106:238-44
105. Terry-McElrath YM, O'Malley PM, Johnston LD. 2014. Alcohol and marijuana use patterns associated with unsafe driving among U.S. high school seniors: high use frequency, concurrent use, and simultaneous use. J. Stud. Alcohol Drugs 75(3):378-89
106. Thies CF, Register CA. 1993. Decriminalization of marijuana and the demand for alcohol, marijuana and cocaine. Soc. Sci. J. 30(4):385-99
107. Thurstone C, Lieberman SA, Schmiege SJ. 2011. Medical marijuana diversion and associated problems in adolescent substance treatment. Drug Alcohol Depend. 118(2-3):489-92
108. Volkow ND, Baler RD, Compton WM, Weiss SRB. 2014. Adverse health effects of marijuana use. N. Engl. J. Med. 370:2219-27
109. Wall MM, Poh E, Cerdá M, Keyes KM, Galea S, Hasin DS. 2011. Adolescent marijuana use from 2002 to 2008: higher in states with medical marijuana laws, cause still unclear. Ann. Epidemiol. 21(9):714-16
110. Wen H, Hockenberry JM, Cummings JR. 2015. The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. J. Health Econ. 42:64-80
111. Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, et al. 2015. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 313(24):2456-73
112. Williams AR, Olfson M, Kim JH, Martins SS, Kleber HD. 2016. Older, less regulated medical marijuana programs have much greater enrollment rates than newer "medicalized" programs. Health Aff. 35(3):480-88
113. Williams J, Mahmoudi P. 2004. Economic relationship between alcohol and cannabis revisited. Econ. Rec. 80(248):36-48
114. Zeisser C, Thompson K, Stockwell T, Duff C, Chow C, et al. 2012. A "standard joint"? The role of quantity in predicting cannabis-related problems. Addict. Res. Theory 20(1):82-92